Dentsply Sirona (XRAY) Byte Aligner Issues Case

• $XRAY investors filed a lawsuit against Dentsply Sirona for misleading them about the safety and compliance of its Byte aligner business.

• On November 7, 2024, Dentsply revealed a $495 million loss on Byte and admitted to serious regulatory problems. Following this, $XRAY stock dropped by 28%.

• $XRAY investors can join this case to be notified about potential recovery.

Case Details:

Between December 2022 and November 2024, Dentsply promoted Byte as a key driver of growth. However, on October 24, 2024, the company announced a voluntary suspension of Byte sales, citing regulatory concerns.

This decision followed discussions with the FDA, during which Dentsply admitted its patient onboarding process had failed to prevent unsuitable patients from entering treatment.

On October 30, 2024, Dentsply further disclosed that its Byte aligners had caused serious injuries to some patients.

The company acknowledged that it had not implemented adequate safety measures and that these issues had been reported to the FDA over several months leading up to the suspension.

These revelations raised significant doubts about Dentsply’s ability to manage the Byte business effectively.

Following the news, $XRAY dropped by 28%.

Based on these events, $XRAY investors filed a lawsuit against Dentsply Sirona, accusing the company of the following:

• It misled investors about Byte’s safety and compliance with regulations.

• It failed to disclose serious problems with its screening process, which caused patient injuries.

Investors believe Dentsply misled them about Byte’s safety, compliance with regulations, and the serious issues with its patient screening.